Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Overall survival (a) and disease-free survival (b) among the entire... | Download Scientific Diagram
High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma | PLOS ONE
Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India
Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy | British Journal of Cancer
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma | Haematologica
VisualAbstract: Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer | 2 Minute Medicine
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
JPM | Free Full-Text | Impact of Tumor LINE-1 Methylation Level and Neoadjuvant Treatment and Its Association with Colorectal Cancer Survival
The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival | SpringerLink
Kaplan-Meier survival curves for disease-free survival and overall... | Download Scientific Diagram
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from ...
Progression-free survival (PFS) (A) and overall survival (OS) (B) based... | Download Scientific Diagram
View Image
PPT - Overall Survival and Progression-Free Survival PowerPoint Presentation - ID:4064400
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Comparison of disease-free survival (DFS) and overall survival (OS)... | Download Scientific Diagram
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
Kaplan-Meier curves for disease-free survival and overall survival... | Download Scientific Diagram
Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer | Experimental Hematology & Oncology | Full Text
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
A) Disease-free survival, (B) progression-free survival and (C)... | Download Scientific Diagram
